Astellas Oncology 2022 C3 (Changing Cancer Care) Prize

The Astellas Oncology C3 (Changing Cancer Care) Prize is a global challenge that funds and advances the best non-treatment ideas to improve cancer care for patients, caregivers and the broader oncology community. Dr. Anthony Yanni, M.D., Senior Vice President and Global Head of Patient Centricity at Astellas, discusses how the C3 Prize has helped innovators fuel their big ideas since it was established in 2016 and how it fits into the company’s patient-centric approach. Dr. Yanni also shares what inspires him the 2022 Grand Prize Winner who will receive a $100,000 grant plus additional resources and hands-on support. 

Anthony is Head of Patient Centricity where he leads the division responsible for creating the global organization, processes and infrastructure necessary to meaningfully integrate the patient perspective into the discovery, development and delivery of innovative healthcare solutions. Previously, he served as the Global Head of Patient Insights, Solutions and Outcomes at Sanofi where he led global teams providing patient-focused support from Discovery through Life-Cycle Strategy. Earlier in his career, he held positions of increasing responsibility and impact in Clinical Development, Translational Science and Medical Intelligence and Patient Perspectives. A Board-certified physician, Anthony also practiced internal medicine for 12 years and served as both Chief of Internal Medicine and Chief Medical Officer of a hospital system. Anthony currently serves on the board of directors for Patient Focused Medical Development (PFMD), a global organization aiming to transform the design and development of research and medicines by focusing on unmet patient needs. Anthony holds an MD from Drexel University School of Medicine, an MBA from the University of Massachusetts and a BS from the University of Scranton.